WRF Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-09-08

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$116M

across 1 round

LATEST ROUND

Series A · $116M · 2026-09-08

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
BrainChild Bio BrainChild Bio develops CAR T cell therapies focused on treating pediatric and adult brain tumors.	Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$116M	2026-09-08	[ PART ]